ROADMAPS: An Online Database of Response Data, Dosing Regimens, and Toxicities of Approved Oncology Drugs as Single Agents to Guide Preclinical In Vivo Studies

by Camalier, R., Collins, J.M, Doroshow, J.H, Gottholm-Ahalt, M., Greenberg, N., Hollingshead, M.G, Johnson, B.C
Published 2022

Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma

by Bischoff, J., Fontaine, F., Francois, M., Graus, M.S, Huang, L., Karnezis, T., McCann, A., Meunier, F., Mulliken, J.B, Seebauer, C.T, Staffa, S.J, Wylie-Sears, J., Zurakowski, D.
Published 2022

Targeting Cellular DNA Damage Responses in Cancer: An In Vitro-Calibrated Agent-Based Model Simulating Monolayer and Spheroid Treatment Responses to ATR-Inhibiting Drugs

by Chaplain, M.A.J, Hamis, S., Powathil, G.G, Yates, J.
Published 2021

Actin-binding protein Anillin promotes the progression of gastric cancer in vitro and in mice

by Gao, Z., Jia, H., Li, B., Yu, F.
Published 2021

Luteolin enhances the antitumor efficacy of oncolytic vaccinia virus that harbors IL-24 gene in liver cancer cells

by Fang, H., Huang, B., Huang, F., Li, Q., Wang, C., Wang, Y., Xiao, B.
Published 2021

Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice

by Allenspach, E.J, Camp, N.D, Georgopoulos, K., James, R.G, Khim, S., Liggitt, H.D, Loftus, J.P, Rawlings, D.J, Tasian, S.K, Thomas, K.R, Timms, A.E, Wray-Dutra, M.N, Zielinska-Kwiatkowska, A.
Published 2022

tRNAIniCAT inhibits proliferation and promotes apoptosis of laryngeal squamous cell carcinoma cells

by Deng, H., Gu, S., Li, J., Luo, L., Shen, Z., Ye, D., Zhou, C.
Published 2021

Development of novel quality control material based on CRISPR/Cas9 editing and xenografts for MLH1 protein deficiency testing

by Chen, Y., Han, D., Han, Y., Li, J., Li, R., Tan, P., Wang, M., Zhang, J., Zhang, R., Zhang, R.
Published 2021

UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line

by Castilho, R.M, Divi, V., Nör, J.E, Oklejas, A.E, Pearson, A.T, Polverini, P.J, Rodriguez-Ramirez, C., Warner, K.A, Wu, W., Zhang, Z.
Published 2018

YBX1 mediates translation of oncogenic transcripts to control cell competition in AML

by Armstrong, S.A, Brandt, S., Eifert, T., Hartmann, M., Hatton, C., Heidel, F.H, Hochhaus, A., Hoell, J.I, Huber, N., Jayavelu, A.K, Mandinova, A., Mann, M., Mashamba, N., Mertens, P.R, Murphy, C., Perner, B., Perner, F., Santamaria, N.T, Schnoeder, T.M, Schröder, N., Todorova, K., Xiong, Y.
Published 2022

Ternary copper(II) complex: NCI60 screening, toxicity studies, and evaluation of efficacy in xenograft models of nasopharyngeal carcinoma

by Ahmad, M., Aziz, N.A, Chu, T.-L, Khoo, A.S.-B, Kornain, N.-K.M, Lo, K.-W, Ng, C.-H, Samiulla, D.S, Suhaimi, S.-N
Published 2018

Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling

by Chen, R.-W, Chen, W.-X, Lin, D.-H, Lin, D.-Q, Xie, W.-J, Xu, J.-P, Ye, W.-L, You, W.-W, Yu, J., Zhang, H.-Q
Published 2021

Long noncoding RNA TUG1 upregulates VEGFA to enhance malignant behaviors in stomach adenocarcinoma by sponging miR-29c-3p

by Cao, J., Cheng, H., Hu, X., Jin, Y.
Published 2021

miR-423-3p activates FAK signaling pathway to drive EMT process and tumor growth in lung adenocarcinoma through targeting CYBRD1

by Bai, X., Feng, Y., Huang, W., Ma, J., Qi, Q., Sun, X., Wang, C., Zhang, L., Zhang, Q., Zhu, C.
Published 2021

Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity

by Lindemann, A., Myers, J.N, Osman, A.A, Patel, A.A, Takahashi, H., Takahashi, Y., Tanaka, N., Zhao, M.
Published 2018

LncRNA MIR4435-2HG functions as a ceRNA against miR-125a-5p and promotes neuroglioma development by upregulating TAZ

by Jin, Y., Pan, Y., Shen, W., Zhang, J.
Published 2021